NCT07642492Not yet recruiting
REcovery After Cancer Application
REcovery After Cancer Application (RECapp) - Personalised Support After Surgery for Oesophageal and Gastric Cancer Patients
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
The RECapp study is a clinical trial evaluating a digital tool designed to support patients recovering from surgery for oesophageal or stomach cancer. The goal is to reduce symptoms and improve quality of life during recovery. Each year in Sweden, around 1,400 people are diagnosed with these cancers. Although more people are surviving thanks to better treatments, recovery after surgery is often long and challenging, with lasting physical and emotional effects. At the same time, healthcare systems are under pressure to provide long-term support. RECapp is a digital platform developed together with patients and healthcare professionals. It includes a mobile app for patients and a web portal for healthcare staff. Patients can track their symptoms, receive personalised self-care advice, and get guidance on when to contact healthcare. Healthcare providers can follow patients' progress remotely. In this study, 250 patients from across Sweden will take part. They will be randomly assigned to either standard care or standard care plus RECapp. Participants will be followed for six months after surgery, and their symptoms and quality of life will be regularly assessed through questionnaires. If RECapp proves effective, it could become part of future cancer care in Sweden-helping patients feel better supported while also making care more efficient.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 5 May 2026
- Start date
- 15 Sept 2026
- Primary completion date
- 15 Dec 2029
- Lead sponsor
- Karolinska Institutet
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07642492
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 15 Sept 2026 to the primary completion date, 15 Dec 2029
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- Cognitive impairment
Who the study is looking for
- Patients who have undergone invasive surgery with curative intent for oesophageal or gastric cancer (including salvage surgery)
- ≥18 years of age
- Ability to read, understand, and complete study materials in Swedish, including consent forms, questionnaires, and instructions
- Access to a smartphone or tablet with personal BankID
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
| Linkoping University Hospital Coordinator of this site? Confirm its status | Linköping | Sweden | Unknown status |
| Skåne University Hospital Coordinator of this site? Confirm its status | Lund | Sweden | Unknown status |
| Örebro University Hospital Coordinator of this site? Confirm its status | Örebro | Sweden | Unknown status |
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
| University Hospital of Umeå Coordinator of this site? Confirm its status | Umeå | Sweden | Unknown status |
| Uppsala University Hospital Coordinator of this site? Confirm its status | Uppsala | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.